Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 184 | 1 | 203 | +20 |
| Shares | 47.7M | 11.9K | 50.7M | +3.01M (+6.3%) |
| Value | $2.34B | $559.0K | $2.24B | −$97.9M (−4.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (23)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Blackstone Group Inc. | 1,048,951 | $51.2M |
| Baker Bros. Advisors LP | 123,600 | $6.03M |
| Ikarian Capital, LLC | 86,035 | $4.20M |
| Penserra Capital Management LLC | 77,192 | $3.76M |
| HealthInvest Partners AB | 76,000 | $3.71M |
| Suvretta Capital Management, LLC | 58,734 | $2.86M |
| Altium Capital Management LP | 50,000 | $2.44M |
| Advisory Research Inc | 43,430 | $2.12M |
| EAM Global Investors LLC | 31,072 | $1.51M |
| EAM Investors, LLC | 21,276 | $1.04M |
| Cornercap Investment Counsel Inc | 20,118 | $981.0K |
| Roman Butler Fullerton & Co | 16,494 | $885.0K |
| SG Americas Securities, LLC | 17,626 | $860.0K |
| Boothbay Fund Management, LLC | 12,711 | $620.0K |
| Gamco Investors, Inc. Et Al | 9,800 | $478.0K |
| Maryland State Retirement & Pension System | 9,224 | $450.0K |
| Dynamic Technology Lab Private Ltd | 7,610 | $371.0K |
| Raymond James & Associates | 6,932 | $338.0K |
| Virtu Financial LLC | 4,207 | $205.0K |
| Lazard Asset Management LLC | 1,566 | $76.0K |
| Captrust Financial Advisors | 432 | $21.0K |
| Parallel Advisors, LLC | 7 | $0 |
| Steward Financial Group LLC | 11 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sheets Smith Investment Management | 11,884 | $559.0K |